Approximately 15% of colorectal cancers (CRCs) display MSI, owing either to epigenetic silencing of MLH1 or to somatic or germline mutations in one of the mismatch repair genes MLH1, MLH3, MSH2, MSH6 or PMS2 (5). Here, MLH1 is linked to colorectal cancer.